Alnylam Pharmaceuticals
ALNY
#650
Rank
$30.13 B
Marketcap
$233.62
Share price
-0.72%
Change (1 day)
19.85%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company